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Assessment of cardiac function continues to be an
important issue in patients with assumed left ventric-
ular (LV) dysfunction [1–10]. In particular in patients
with enlarged left ventricles, such as occurs in
ischemic and idiopathic dilated cardiomyopathy,
accurate assessment of LV function remains pivotal
[11–14]. To assess myocardial function, different
diagnostic methods are currently performed such as
echocardiography, single photon emission computed
tomography (SPECT), and cardiac magnetic reso-
nance imaging (CMR) [15–23]. In the clinical arena,
detection of myocardial function is predominantly
based on echocardiographic studies. In addition,
nuclear techniques, showing preserved tracer uptake
and metabolism in viable myocardium, may also
assess left ventricular function and wall motion.
Volumetric analysis by gated SPECT imaging offers
considerable additional value to SPECT myocardial
perfusion imaging in characterizing functional abnor-
malities thereby potentially improving test speciﬁcity
[24–37]. Subsequent to echocardiography and gated
SPECT imaging, CMR has now long been recognized
as an accurate and reliable means of evaluating LV
function. Considerable progress has been made in the
ﬁeld of CMR, providing accurate evaluation of LV
function parameters in coronary artery disease, heart
failure, hypertrophic cardiomyopathy, and many
other cardiac diseases [38–49]. CMR may be more
accurate than echocardiography and gated SPECT in
establishing LV volumetric parameters because of its
more objective analysis and superb spatial resolution,
respectively [50–58].
In the current issue of the International Journal of
Cardiovascular Imaging, Holloway et al. [59] nicely
determined the accuracy of visual analysis of LV
function in comparison with the accepted quantitative
reference standard CMR. Cine CMR imaging was
performed at 1.5 T on 44 patients with a range of LV
ejection fractions (EF) between 5 and 80%. Eighteen
clinicians were asked to visually assess LVEF after
sequentially being shown cine images of a four-
chamber (horizontal long axis), two-chamber (verti-
cal long axis) and a short axis stack. The authors
found strong correlations between visual and quan-
titative assessment. However, LVEF was underesti-
mated in all categories (by 8.4% for horizontal long
axis, 8.4% for horizontal long axis ? vertical long
axis and 7.9% for horizontal long axis ? vertical
long axis ? short axis stack). LVEF was particularly
underestimated in patients with mild LV dysfunction
(17.4%, P\0.01), less for moderate (4.9%) and not
for severe impairment (1%). It was concluded that
assessing more than one view of the heart improved
visual assessment of LVEF. However, the 18
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with particular inaccuracy for those patients with
mild LV dysfunction. Given the important clinical
information provided by LV assessment, in particular
in deformed left ventricles, the authors recommended
quantitative analysis for accurate assessment of LV
function.
Several studies have compared visual and quanti-
tative assessment of LVEF, both in normal subjects
and patients with impaired LV function [60–68].
Nearly all studies showed that LVEF is underesti-
mated by visual estimation compared with the
quantitative assessment. Holman et al. [65], using a
dedicated analytical software package (MASS ver-
sion 1.0) including a modiﬁed centerline method and
a new 3D-analysis approach, showed in 25 patients
after acute myocardial infarction that the use of three-
dimensional quantitative analysis of cine CMR
images accurately quantiﬁes the extent of regional
LV dysfunction in the infarcted heart. Van der Geest
et al. [66] evaluated a computer algorithm for the
automated detection of LV endocardial and epicardial
boundaries in time series of short-axis CMR images
based on an Active Appearance Motion Mode. In 20
short-axis CMR examinations, manual contours were
deﬁned in multiple temporal frames (from end-
diastole to end-systole) in multiple slices from base
to apex. Global LV function results derived from
automatically detected contours were compared with
results obtained from manually traced boundaries.
Automated contour detection resulted in small, but
statistically non-signiﬁcant, underestimations of LV
volumes and mass: and an excellent agreement was
observed in the LVEF. The fully automated contour
detection method provided assessment of quantitative
global LV function that is comparable to manual
analysis, but offered the advantage of being more
consistent, more reproducible, and less operator-
dependent. Sievers et al. [67] investigated 100
subjects (40 normal subjects, 40 patients with ische-
mic cardiomyopathy, and 20 patients with nonis-
chemic cardiomyopathy) using a 1.5-T CMR imager.
LVEF was signiﬁcantly underestimated by the visual
reader in all 3 groups. The difference was larger in
normal subjects than in patients with cardiomyopa-
thy. The interobserver variability was smaller for the
quantitative assessment than for the visual estimation.
Attili et al. [69] reported that recent quantitation-
oriented advances in CMR hardware and software
have resulted in signiﬁcant improvements in image
quality and a reduction in imaging time.
To conclude, the study by Holloway et al. [59]
conﬁrms that the visual CMR approach for LVEF
assessment may be used for rapid assessment of LV
function in clinical practice where accuracy is of less
concern. For an accurate analysis of LV function, the
quantitative standard short axis approach is required.
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